CD274 and neoplasm: A key finding of this study is that there exist patients with high tumour PD-L1 expression in the absence of abundant TILs, and this clinically relevant finding supports the need for checkpoint marker staining, rather than a solely morphology-based TILs assessment as a predictive biomarker.